CVM Updates

Current and past CVM Updates

Outbreaks and Advisories

FDA News

• Lyndonville Woman Sentenced for Selling Misbranded Pet Medications
• Supervisor at Long Island Drug Manufacturer Sentenced to Prison for Theft of Medical Products
• Operator of Portland Animal Rescue Business Charged for Role in Wire Fraud Conspiracy, Illegally Dispensing Animal Drugs
• Federal judge enters consent decree against New Jersey raw animal food manufacturer
• FDA Seeks $8.4 Billion to Further Investments in Critical Public Health Modernization, Core Food and Medical Product Safety Programs
• Harness Trainer Christopher Oakes Sentenced To 3 Years In Federal Doping Case
• FDA Urges Companies to be ’Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls
• FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
• Horse Doping Drug Supplier Convicted In Manhattan Federal Court
• Former Veterinarian Pleads Guilty to Drug Charges
• Operator of Illegal Veterinary Pharmacy Pleads Guilty
• Prolific Thoroughbred Trainer Sentenced To Five Years In Federal Doping Case
• Court Enjoins California Company from Manufacturing and Distributing Adulterated Sterile Animal Drugs
• Owner Of Illegal Racehorse Doping Websites Sentenced To 18 Months In Prison
• FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse Events
• FDA In Brief: FDA Reminds Industry of Specific Regulations for the Use of Fluorinated Polyethylene in Food Contact Containers
• Owner Of Illegal Racehorse Doping Websites Pleads Guilty In Manhattan Federal Court
• Operator of Racehorse Doping Websites Sentenced to 18 Months in Prison
• FDA Warns Companies Illegally Selling CBD Products
• FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses 
• Former Supervisor at Long Island Drug Manufacturer Pleads Guilty to Theft of Medical Products
• Department of Justice Files Complaint Against California Company To Stop Distribution of Adulterated Animal Drugs
• FDA Launches New Era of Smarter Food Safety Initiative, Releases Blueprint and Pilot Study
• Remarks by Dr. Hahn on the release of a Blueprint for A New Era of Food Safety
• Animal Health International Sentenced on Federal Misbranding Charge
• FDA Requests Removal of All Ranitidine Products (Zantac) from the Market 
  CVM is sharing this information with our subscribers because ranitidine is also used in veterinary medicine.
• Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products
• FDA Offers Assurance About Food Safety and Supply for People and Animals During COVID-19 
• Coronavirus (COVID-19) Update: FDA Helps Facilitate Veterinary Telemedicine During Pandemic
• Medical Glove Conservation Strategies: Letter to Health Care Providers
• Coronavirus (COVID-19) Update: FDA Focuses on Safety of Regulated Products While Scaling Back Domestic Inspections
• Coronavirus (COVID-19) Update: FDA Issues Temporary Policy for FSMA Onsite Audit Requirements
• Surgical Mask and Gown Conservation Strategies - Letter to Healthcare Providers
• FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity
• FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals
• Collegeville Man Indicted for Scheme to Sell Fraudulent Canine Cancer-Curing Drugs to Pet Owners
• FDA, USDA and EPA announce joint platform to streamline information about agricultural biotechnology products
• FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
• Individual Indicted And Arrested For Illegally Producing And Shipping Adulterated And Misbranded Animal Drugs Without A License
• Statement on FDA’s new report regarding root causes and potential solutions to drug shortages
• Statement on measuring the progress being made through implementing the FDA Food Safety Modernization Act
• FDA Announces Public Meeting to Discuss the New Era of Smarter Food Safety
• FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety
• Federal judge enters consent decree against Arkansas food and medical product grocery warehouse for insanitary conditions
• What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
• Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls